To determine the prognostic role of extranodal extension (ENE) among patients with human papilloma virus–positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) through a systematic review and meta-analysis of institutional studies.
Data Sources
MEDLINE, Embase, Scopus, and PubMed.
Review Methods
Two independent authors searched the databases on December 3, 2019, to identify studies of HPV+ OPSCC comparing prognostic outcomes stratified by ENE. The I2 statistic was used to determine study heterogeneity. Fixed and random effects models were used to determine hazard ratios (HRs) with 95% CIs.
Results
Eighteen observational studies met inclusion criteria, yielding 3603 patients with HPV+ OPSCC (1521 ENE+ and 2082 ENE–) with a median follow-up of 49 months. The presence of pathologic ENE (pENE) and radiologic ENE (rENE) was associated with decreased overall survival (pENE HR, 1.89 [95% CI, 1.15-3.13], I2 = 35%; rENE HR, 2.64 [95% CI, 1.46-4.78], I2 = 75%) and distant recurrence (pENE HR, 3.23 [95% CI, 1.25-8.33], I2 = 0%; rENE HR, 3.83 [95% CI, 1.88-7.80], I2 = 0%). Neither pENE nor rENE was associated with locoregional recurrence (pENE HR, 0.75 [95% CI, 0.20-2.84], I2 = 0%; rENE HR, 2.03 [95% CI, 0.86-4.79], I2 = 0%). pENE was not associated with disease-specific survival (pENE HR, 1.45 [95% CI, 0.84-2.49], I2 = 0%).
Conclusion
pENE and rENE are moderately associated with an increased risk of all-cause mortality and recurrence with distant metastasis in a cohort of patients with HPV+ OPSCC. These findings may be used to inform exclusion criteria for deintensification trials and assist in refined risk stratification.
CarterRLBarrLCO’BrienCJSooKCShawHJ. Transcapsular spread of metastatic squamous cell carcinoma from cervical lymph nodes. Am J Surg. 1985;150(4):495-499.
2.
MermodMTolstonogGSimonCMonnierY. Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol. 2016;62:60-71.
3.
BernierJCooperJSPajakTF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27(10):843-850.
4.
BernierJDomengeCOzsahinM, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945-1952.
5.
CooperJSPajakTFForastiereAA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-1944.
SinhaPPiccirilloJFKallogjeriDSpitznagelELHaugheyBH. The role of postoperative chemoradiation for oropharynx carcinoma: a critical appraisal of the published literature and National Comprehensive Cancer Network guidelines. Cancer. 2015;121(11):1747-1754.
8.
MyersJNGreenbergJSMoVRobertsD. Extracapsular spread: a significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001;92(12):3030-3036.
9.
LiuBGuanCJiWYPanZM. Extracapsular spread in ipsilateral neck metastasis: an important prognostic factor in laryngeal cancer. Chin Med Sci J. 2006;21(2):86-89.
10.
DunneAAMullerHHEiseleDWKesselKMollRWernerJA. Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. Eur J Cancer. 2006;42(12):1863-1868.
11.
O’SullivanBLydiattWHaugheyBH, et al. HPV-mediated (p16þ) oropharyngeal cancer. In: AminMEdgeSGreeneF, et al, eds. AJCC Cancer Staging Manual. 8th ed.Springer; 2017:113-121.
12.
MaxwellJHFerrisRLGoodingW, et al. Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer. 2013;119(18):3302-3308.
13.
SinhaPKallogjeriDGayH, et al. High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Oral Oncol. 2015;51(5):514-520.
14.
HaugheyBHSinhaPKallogjeriD, et al. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol. 2016;62:11-19.
15.
LydiattWMPatelSGO’SullivanB, et al. Head and neck cancers—major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122-137.
16.
LiHTorabiSJParkHS, et al. Clinical value of transoral robotic surgery: nationwide results from the first 5 years of adoption. Laryngoscope. 2019;129(8):1844-1855.
17.
WilkieMDUpileNSLauAS, et al. Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: a paradigm shift in therapeutic approach. Head Neck. 2016;38(8):1263-1270.
18.
SchmittNCDuvvuriU. Transoral robotic surgery for oropharyngeal squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2015;23(2):127-131.
19.
NixonL. Post-operative adjuvant treatment for HPV-positive tumours (PATHOS). ClinicalTrials.gov identifier: NCT02215265. Accessed February 13, 2019. https://clinicaltrials.gov/ct2/show/NCT02215265
20.
Eastern Cooperative Oncology Group, National Cancer Insitute. Transoral surgery followed by low-dose or standard-dose radiation therapy with or without chemotherapy in treating patients with HPV positive stage III-IVA oropharyngeal cancer. ClinicalTrials.gov identifier: NCT01898494. Accessed February 2020. https://ClinicalTrials.gov/show/NCT01898494
21.
AminiAJasemJJonesBL, et al. Predictors of overall survival in human papillomavirus–associated oropharyngeal cancer using the National Cancer Data Base. Oral Oncol. 2016;56:1-7.
22.
ZhanKYEskanderAKangSY, et al. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Oral Oncol. 2017;73:152-159.
23.
AnYParkHSKellyJR, et al. The prognostic value of extranodal extension in human papillomavirus–associated oropharyngeal squamous cell carcinoma. Cancer. 2017;123(14):2762-2772.
24.
MiccioJAVermaVKellyJ, et al. Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition. Oral Oncol. 2019;99:104447.
25.
KumarBCipollaMJOldMO, et al. Surgical management of oropharyngeal squamous cell carcinoma: survival and functional outcomes. Head Neck. 2016;38(suppl 1):E1794-E1802.
26.
Billfalk-KellyAYuESuJ, et al. Radiologic extranodal extension portends worse outcome in cN+ TNM-8 stage I human papillomavirus–mediated oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2019;104(5):1017-1027.
27.
MoherDLiberatiATetzlaffJAltmanDGPRISMA-P Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-341.
28.
WellsGASheaBO’ConnellDPJWelchVLososMTP. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute; 2014. Accessed January 3, 2019. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
29.
The Nordic Cochrane Centre. Review Manager (RevMan). Version 5.3. The Cochrane Collaboration;2014.
30.
TierneyJFStewartLAGhersiDBurdettSSydesMR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
31.
HigginsJPTGreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration; 2011.
32.
HigginsJPThompsonSGDeeksJJAltmanDG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
33.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
34.
ValentineJCPigottTDRothsteinHR. How many studies do you need? A primer on statistical power for meta-analysis. J Edu Behav Stats. 2010;35(2):215-247.
35.
EggerMDavey SmithGSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
36.
DuvalSTweedieR. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.
37.
BeltzAGossweinDZimmerS, et al. Staging of oropharyngeal squamous cell carcinoma of the head and neck: prognostic features and power of the 8th edition of the UICC staging manual. Eur J Surg Oncol. 2019;45(6):1046-1053.
38.
IyerNGDoganSPalmerF, et al. Detailed analysis of clinicopathologic factors demonstrate distinct difference in outcome and prognostic factors between surgically treated HPV-positive and negative oropharyngeal cancer. Ann Surg Oncol. 2015;22(13):4411-4421.
39.
KaczmarJMTanKSLinA, et al. HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with surgery (TORS). Int J Radiat Oncol Biol Phys. 2014;88(2):491.
40.
KharytaniukNMolonyPBoyleS, et al. Association of extracapsular spread with survival according to human papillomavirus status in oropharynx squamous cell carcinoma and carcinoma of unknown primary site. JAMA Otolaryngol Head Neck Surg. 2016;142(7):683-690.
41.
KlozarJKoslabovaEKratochvilVSalakovaMTachezyR. Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol. 2013;107(6):625-633.
42.
LukensJNTangsriwongKMitraN, et al. Pathological factors predicting the risk of distant failure for human papillomavirusepositive oropharyngeal squamous cell carcinoma (OPSCC). Int J Radiat Oncol Biol Phys. 2015;1:S77.
43.
ParkYMKangMSKohYWChoiECKimSH. Does p16+ predict a favorable prognosis for oropharyngeal cancer? Risk factors for treatment failure for patients who underwent surgery-based therapy. Ann Surg Oncol. 2019;26(2):547-554.
44.
ShevachJBossertABakstRL, et al. Extracapsular extension is associated with worse distant control and progression-free survival in patients with lymph node–positive human papillomavirus–related oropharyngeal carcinoma. Oral Oncol. 2017;74:56-61.
45.
SinhaPLewisJSJrPiccirilloJFKallogjeriDHaugheyBH. Extracapsular spread and adjuvant therapy in human papillomavirus–related, p16-positive oropharyngeal carcinoma. Cancer. 2012;118(14):3519-3530.
46.
BhattasaliOThompsonLDRSchumacherAJIganejS. Radiographic nodal prognostic factors in stage I HPV-related oropharyngeal squamous cell carcinoma. Head Neck. 2019;41(2):398-402.
47.
HuangSHO’SullivanBSuJ, et al. Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification. Radiother Oncol. 2020;144:13-22.
48.
ThompsonLDRBurchetteRIganejSBhattasaliO. Oropharyngeal squamous cell carcinoma in 390 patients: analysis of clinical and histological criteria which significantly impact outcome. Head Neck Pathol. Published online November18, 2019. doi:10.1007/s12105-019-01096-0
49.
TianSFerrisMJSwitchenkoJM, et al. Prognostic value of radiographically defined extranodal extension in human papillomavirus–associated locally advanced oropharyngeal carcinoma. Head Neck. 2019;41(9):3056-3063.
50.
KaczmarJMTanKSHeitjanDF, et al. HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head Neck. 2016;38(1):59-65.
51.
TianSFerrisMJSwitchenkoJ, et al. Prognostic value of radiographically-defined extranodal extension is modulated by human papillomavirus status in locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2017;99(2)(suppl 1):E216-E17.
52.
MermodMTolstonogGSimonCMonnierY. Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol. 2016;62:60-71.
53.
TassonePCrawleyMBovenziC, et al. Pathologic markers in surgically treated HPV-associated oropharyngeal cancer: retrospective study, systematic review, and meta-analysis. Ann Otol Rhinol Laryngol. 2017;126(5):365-374.
54.
HaugheyBHSinhaP. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope. 2012;122(suppl 2):S13-S33.
55.
IyerNGDoganSPalmerF, et al. Detailed analysis of clinicopathologic factors demonstrate distinct difference in outcome and prognostic factors between surgically treated HPV-positive and negative oropharyngeal cancer. Ann Surg Oncol. 2015;22(13):4411-4421.
56.
MaxwellJHFerrisRLGoodingW, et al. Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status. Cancer. 2013;119(18):3302-3308.
57.
KlozarJKoslabovaEKratochvilVSalakovaMTachezyR. Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J Surg Oncol. 2013;107(6):625-633.
58.
KumarBCipollaMJOldMO, et al. Surgical management of oropharyngeal squamous cell carcinoma: survival and functional outcomes. Head Neck. 2016;38(suppl 1):E1794-E802.
59.
BauerEMazulAChernockR, et al. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma. Laryngoscope. 2020;130(4):939-945.
60.
SinhaPKallogjeriDGayH, et al. High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Oral Oncol. 2015;51(5):514-520.
61.
HuangSHSYuEBillfalk-KellyA, et al. Radiologic extranodal extension portends worse outcome in TNM-8 cT1-T2N1 HPV+ oropharyngeal cancer. Radiother Oncol. 2019;132(suppl 1):7-8.
62.
SinhaPLewisJSKallogjeriDNussenbaumBHaugheyBH. Soft tissue metastasis in p16-positive oropharynx carcinoma: prevalence and association with distant metastasis. Oral Oncol. 2015;51(8):778-786.
63.
MaxwellJHRathTJByrdJK, et al. Accuracy of computed tomography to predict extracapsular spread in p16-positive squamous cell carcinoma. Laryngoscope. 2015;125(7):1613-1618.
64.
ChaiRLRathTJJohnsonJT, et al. Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1187-1194.
65.
GensheimerMFLeQT. Radiographic extranodal extension in human papillomavirus–associated oropharyngeal carcinoma: can it help tailor treatment?Int J Radiat Oncol Biol Phys. 2019;104(5):1028-1029.
66.
PrabhuRSMaglioccaKRHanasogeS, et al. Accuracy of computed tomography for predicting pathologic nodal extracapsular extension in patients with head-and-neck cancer undergoing initial surgical resection. Int J Radiat Oncol Biol Phys. 2014;88(1):122-129.
67.
AlmullaANoelCWLuL, et al. Radiologic-pathologic correlation of extranodal extension in patients with squamous cell carcinoma of the oral cavity: implications for future editions of the TNM classification. Int J Radiat Oncol Biol Phys. 2018;102(4):698-708.
68.
YanFByunYJNguyenSAStalcupSTDayTA. Predictive value of computed tomography in identifying extranodal extension in human papillomavirus–positive versus human papillomavirus–negative head and neck cancer. Head Neck. Published online June2, 2020. doi:10.1002/hed.26281
69.
KannBHAnejaSLoganadane, et al. Pretreatment identification of head and neck cancer nodal metastasis and extranodal extension using deep learning neural networks. Sci Rep. 2018;8(1):14036.
70.
DziegielewskiPTTeknosTNDurmusK, et al. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1099-1108.
71.
ParsonsJTMendenhallWMStringerSP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94(11):2967-2980.
72.
MachtayMMoughanJTrottiA, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-3589.
73.
BossiPCossu RoccaMCorvoR, et al. The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity. Crit Rev Oncol Hematol. 2017;116:82-88.
74.
DenisFGaraudPBardetE, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22(1):69-76.
75.
KellyJRParkHSAnY, et al. Upfront surgery versus definitive chemoradiotherapy in patients with human papillomavirus–associated oropharyngeal squamous cell cancer. Oral Oncol. 2018;79:64-70.
76.
SubramanianHEParkHSBarbieriA, et al. Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study. Cancers Head Neck. 2016;1:7.
77.
HuangSHHansenARathodSO’SullivanB. Primary surgery versus (chemo)radiotherapy in oropharyngeal cancer: the radiation oncologist’s and medical oncologist’s perspectives. Curr Opin Otolaryngol Head Neck Surg. 2015;23(2):139-147.
78.
LiaoCTChangJTWangHM, et al. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2009;74(4):1054-1061.
79.
JooYHYooIRChoKJParkJONamICKimMS. Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2013;42(2):158-163.
80.
Brasilino de CarvalhoM. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck. 1998;20(1):16-21.
81.
HirabayashiHKoshiiKUnoK, et al. Extracapsular spread of squamous cell carcinoma in neck lymph nodes: prognostic factor of laryngeal cancer. Laryngoscope. 1991;101(5):502-506.
82.
KompelliARMorganPLiHHarrisWDayTANeskeyDM. Prognostic impact of high-risk pathologic features in HPV-related oropharyngeal squamous cell carcinoma and tobacco use. Otolaryngol Head Neck Surg. 2019;160(5):855-861.
83.
ShawRJLoweDWoolgarJA, et al. Extracapsular spread in oral squamous cell carcinoma. Head Neck. 2010;32(6):714-722.
84.
SilkAWMcTigueKM. Reexamining the physical examination for obese patients. JAMA. 2011;305(2):193-194.
85.
WangYBeydounMAMinJXueHKaminskyLACheskinLJ. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int J Epidemiol. 2020;49(3):810-823.
86.
CooperJSPajakTFForastiereA, et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?Head Neck. 1998;20(7):588-594.
87.
BachaudJMDavidJMBoussinGDalyN. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys. 1991;20(2):243-246.
88.
O’SullivanBHuangSHSiuLL, et al. Deintensification candidate subgroups in human papillomavirus–related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013;31(5):543-550.
89.
HuangSHPerez-OrdonezBWeinrebI, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol. 2013;49(1):79-85.
90.
NRG Oncology, National Cancer Institute. Reduced-dose intensity-modulated radiation therapy with or without cisplatin in treating patients with advanced oropharyngeal cancer. ClinicalTrials.gov identifier: NCT02254287. Accessed December 20, 2019. https://clinicaltrials.gov/ct2/show/NCT02254278
91.
NixonL. Post-operative adjuvant treatment for HPV-positive tumours (PATHOS). ClinicalTrials.gov identifier: NCT02215265. Accessed February 13, 2019. https://clinicaltrials.gov/ct2/show/NCT02215265
92.
JohnsonACEthunCGLiuY, et al. Studying a rare disease using multi-institutional research collaborations vs big data: where lies the truth?J Am Coll Surg. 2018;227(3):357-366, e3.
93.
LyuHGHaiderAHLandmanABRautCP. The opportunities and shortcomings of using big data and national databases for sarcoma research. Cancer. 2019;125(17):2926-2934.
94.
HoskinTLBougheyJCDayCNHabermannEB. Lessons learned regarding missing clinical stage in the National Cancer Database. Ann Surg Oncol. 2019;26(3):739-745.
95.
O’SullivanB. Head and neck tumours. In: BrierleyJGospodarowiczMChW, et al, eds. UICC TNM Classification of Malignant Tumours. 8th ed. John Wiley & Sons; 2017:17-54.
96.
O’SullivanBHuangSHSuJ, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440-451.
97.
LewisJSJrCarpenterDHThorstadWLZhangQHaugheyBH. Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol. 2011;24(11):1413-1420.
98.
AnYParkHSKellyJR, et al. The prognostic value of extranodal extension in human papillomavirus–associated oropharyngeal squamous cell carcinoma. Cancer. 2017;123(14):2762-2772.
99.
VainshteinJMSpectorMEIbrahimM, et al. Matted nodes: high distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus–related oropharyngeal cancer. Head Neck. 2016;38(suppl 1):E805-E814.
100.
van den BrekelMWLodderWLStelHVBloemenaELeemansCRvan der WaalI. Observer variation in the histopathologic assessment of extranodal tumor spread in lymph node metastases in the neck. Head Neck. 2012;34(6):840-845.
101.
FarajiFEiseleDWFakhryC. Emerging insights into recurrent and metastatic human papillomavirus–related oropharyngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2017;2(1):10-18.
102.
SinhaPHaugheyBHKallogjeriDJacksonRS. Long-term analysis of transorally resected p16 + oropharynx cancer: outcomes and prognostic factors. Laryngoscope. 2018;129(5):1141-1149.
103.
FinnOJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol. 2012;23(suppl 8):viii6-9.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
